We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cardinal Health will pay $11 million to settle an investigation by the New York Attorney General’s Office into the purchase and sale of pharmaceutical products on the secondary market, the company announced.
Actavis announced an agreement to acquire all controlling shares of Abrika Pharmaceuticals, a specialty generic drugmaker focused on developing controlled-release pharmaceuticals.
Merck and Idera Pharmaceuticals announced a collaboration to incorporate Idera’s toll-like receptor (TLR) agonists into vaccines Merck is developing for oncology, infectious diseases and Alzheimer’s disease.
Generic drug manufacturer Teva Pharmaceutical and its subsidiary Sicor will continue marketing the cancer drug idarubicin and the antibiotic azithromycin, the generic versions of Pfizer's Idamycin and Zithromax, according to the terms of a settlement agreement the two companies have reached. Read More
HHS has awarded nearly $200 million in contracts with sanofi pasteur, GlaxoSmith-Kline (GSK) and Novartis to increase the national stockpile of pre-pandemic bird flu vaccine. Read More
Generic drug manufacturer Teva Pharmaceutical and its subsidiary Sicor will continue marketing the cancer drug idarubicin and the antibiotic azithromycin, the generic versions of Pfizer’s Idamycin and Zithromax, according to the terms of a settlement agreement the two companies reached this week. Read More
HHS has awarded nearly $200 million in contracts with sanofi pasteur, GlaxoSmithKline (GSK) and Novartis to increase the national stockpile of pre-pandemic bird flu vaccine. Read More